Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Clinical trial NCT07404865 · RECRUITING

Trial details

NCT number: NCT07404865
Sponsor: Vor Biopharma
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Sjogren's Disease

Start date: 2026-02-26
Primary completion: 2028-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.